MXPA02009839A - Remedios para enfermedades debidas a lesiones estenoticas de vasos sanguineos. - Google Patents

Remedios para enfermedades debidas a lesiones estenoticas de vasos sanguineos.

Info

Publication number
MXPA02009839A
MXPA02009839A MXPA02009839A MXPA02009839A MXPA02009839A MX PA02009839 A MXPA02009839 A MX PA02009839A MX PA02009839 A MXPA02009839 A MX PA02009839A MX PA02009839 A MXPA02009839 A MX PA02009839A MX PA02009839 A MXPA02009839 A MX PA02009839A
Authority
MX
Mexico
Prior art keywords
remedies
blood vessel
diseases due
stenotic lesions
stenotic
Prior art date
Application number
MXPA02009839A
Other languages
English (en)
Inventor
Hiroyuki Matsuno
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of MXPA02009839A publication Critical patent/MXPA02009839A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
MXPA02009839A 2000-04-06 2001-04-05 Remedios para enfermedades debidas a lesiones estenoticas de vasos sanguineos. MXPA02009839A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000104344 2000-04-06
PCT/JP2001/002946 WO2001076587A1 (fr) 2000-04-06 2001-04-05 Remedes aux maladies associees aux lesions stenosees de vaisseaux sanguins

Publications (1)

Publication Number Publication Date
MXPA02009839A true MXPA02009839A (es) 2003-09-22

Family

ID=18617901

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02009839A MXPA02009839A (es) 2000-04-06 2001-04-05 Remedios para enfermedades debidas a lesiones estenoticas de vasos sanguineos.

Country Status (15)

Country Link
US (1) US20040068015A1 (es)
EP (1) EP1275385A1 (es)
JP (1) JPWO2001076587A1 (es)
KR (1) KR20020087124A (es)
CN (1) CN1434709A (es)
AU (1) AU4683601A (es)
BR (1) BR0109889A (es)
CA (1) CA2404775A1 (es)
HU (1) HUP0300368A3 (es)
MX (1) MXPA02009839A (es)
NO (1) NO20024821L (es)
RU (1) RU2002126568A (es)
TW (1) TW575421B (es)
WO (1) WO2001076587A1 (es)
ZA (1) ZA200207974B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120083477A1 (en) 2009-05-27 2012-04-05 Yeda Research And Development Co. Ltd. Proteasome inhibitors and uses thereof
BR112020013342A2 (pt) * 2018-02-01 2020-12-01 Wellstat Therapeutics Corporation composições e dispositivos para fornecimento sistêmico de uridina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843089A (en) * 1990-12-28 1998-12-01 Boston Scientific Corporation Stent lining
US5516781A (en) * 1992-01-09 1996-05-14 American Home Products Corporation Method of treating restenosis with rapamycin
JP3628335B2 (ja) * 1996-01-23 2005-03-09 塩野義製薬株式会社 スルホン化されたアミノ酸誘導体およびそれを含有するメタロプロティナーゼ阻害剤
EP1024134A4 (en) * 1997-10-09 2003-05-14 Ono Pharmaceutical Co DERIVATIVES OF AMINOBUTANIC ACID

Also Published As

Publication number Publication date
RU2002126568A (ru) 2004-03-20
CN1434709A (zh) 2003-08-06
HUP0300368A3 (en) 2004-07-28
NO20024821D0 (no) 2002-10-04
TW575421B (en) 2004-02-11
WO2001076587A1 (fr) 2001-10-18
AU4683601A (en) 2001-10-23
CA2404775A1 (en) 2002-10-02
HUP0300368A2 (hu) 2003-07-28
KR20020087124A (ko) 2002-11-21
EP1275385A1 (en) 2003-01-15
NO20024821L (no) 2002-12-06
ZA200207974B (en) 2004-02-10
JPWO2001076587A1 (ja) 2004-01-08
BR0109889A (pt) 2003-06-03
US20040068015A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU6157901A (en) Delivery systems for treatment of vascular disease
AU6408901A (en) Early diagnosis of conformational diseases
AP2003002842A0 (en) Phenethanolamine derivatives for treatment of respiratory disease.
AU5114601A (en) Method for the treatment of dermal lesions caused by envenomation
AU2956101A (en) Improved lumen design for catheter
HK1037861A1 (en) Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
GB0015745D0 (en) Treatment of bone diseases
EP1459759A4 (en) MEDICAMENT FOR THE MOBILIZATION OF PLURIPOTENTIAL STEM CELLS FROM TISSUE IN THE PERIPHERAL BLOOD
AU2002216897A1 (en) Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
HUP0203303A3 (en) Compositions for administering taxanes orally to human patients
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
AU2002368219A1 (en) Dermatological preparation for the treatment of skin lesions
IL141950A0 (en) Diagnosis of prion diseases
MXPA02009839A (es) Remedios para enfermedades debidas a lesiones estenoticas de vasos sanguineos.
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU9545701A (en) Use of carp inhibitors for the treatment of heart diseases
EP1304117A4 (en) MEDIUM FOR BONE DISEASES
EP1426762A4 (en) DRUGS FOR CARDIAC DISEASES
EP1252895A4 (en) REMEDIES FOR OPHTHALMIC DISORDERS
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
ZA200300675B (en) Pharmaceutical preparation of the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma.
ITBO990038A0 (it) Pomata per la cura delle lesioni cutanee particolarmente delle ustioni .
AU2001241778A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular, hepatic, and bone disease
AU2001241974A1 (en) Actinomycin d for the treatment of vascular disease